Our results suggest LIUS and DOX combination treatment suppresses tumor growth, prolongs survival, increases the expression of MMP-2 and MMP-9, and promotes the deposition of collagen fibers in OSCC xenograft. The gene discussed is MMP2; the disease is neoplasm.